SUBSEQUENT EVENTS	9 Months Ended
Dec. 31, 2021
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 10 – SUBSEQUENT EVENTS Bridge Note Subsequent to December 31, 2021, the Company made additional draws totaling $600,000 under the Bridge Note. Public Offering On February 9, 2022, the Company entered into an underwriting agreement (the Underwriting Agreement), with Oppenheimer & Co. Inc., which acted as the representative of the several underwriters (the “Representative”), in a firm commitment underwritten public offering (the Offering) pursuant to which the Company agreed to sell to the Representative an aggregate of 2,500,000 shares of the Company’s common stock, par value $0.001 per share (the Common Stock), and 2,500,000 warrants (Warrants and, collectively with the Common Stock, the Units), each to purchase one share of Common Stock, at a public offering price of $6.00 per Unit. The Warrants included in the Units are exercisable immediately, have an exercise price of $6.60 per share and expire five years from the date of issuance. The Common Stock was approved to list on the Nasdaq Capital Market under the symbol “MODD” and began trading there on February 10, 2022. The gross proceeds from the Offering were $15 million, before deducting underwriting discounts and commissions and other offering expenses. The Units were offered and sold to the public pursuant to the Company’s registration statement on Form S-1 (File No. 333-260682), initially filed by the Company with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the Securities Act), on November 2, 2021, and declared effective on February 9, 2022. The Underwriting Agreement contains customary representations, warranties and agreements by the Company, customary conditions to closing, indemnification obligations of the Company and the Representative, including for liabilities under the Securities Act of 1933, as amended, other obligations of the parties and termination provisions. In addition, pursuant to the terms of the Underwriting Agreement and related “lock-up” agreements, the Company, each director and executive officer of the Company, and certain stockholders have agreed with the Representative not to offer for sale, issue, sell, contract to sell, pledge or otherwise dispose of any of our Common Stock or securities convertible into Common Stock for a period of 180 days after February 9, 2022, the date of the final prospectus.

SUBSEQUENT EVENTS

9 Months Ended

Dec. 31, 2021

NOTE 10 – SUBSEQUENT EVENTS

Bridge Note

Subsequent to December 31, 2021, the Company made additional draws totaling $600,000 under the Bridge Note.

Public Offering

On February 9, 2022, the Company entered into an underwriting agreement (the Underwriting Agreement), with Oppenheimer & Co. Inc., which acted as the representative of the several underwriters (the “Representative”), in a firm commitment underwritten public offering (the Offering) pursuant to which the Company agreed to sell to the Representative an aggregate of 2,500,000 shares of the Company’s common stock, par value $0.001 per share (the Common Stock), and 2,500,000 warrants (Warrants and, collectively with the Common Stock, the Units), each to purchase one share of Common Stock, at a public offering price of $6.00 per Unit. The Warrants included in the Units are exercisable immediately, have an exercise price of $6.60 per share and expire five years from the date of issuance. The Common Stock was approved to list on the Nasdaq Capital Market under the symbol “MODD” and began trading there on February 10, 2022. The gross proceeds from the Offering were $15 million, before deducting underwriting discounts and commissions and other offering expenses.

The Units were offered and sold to the public pursuant to the Company’s registration statement on Form S-1 (File No. 333-260682), initially filed by the Company with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the Securities Act), on November 2, 2021, and declared effective on February 9, 2022.

The Underwriting Agreement contains customary representations, warranties and agreements by the Company, customary conditions to closing, indemnification obligations of the Company and the Representative, including for liabilities under the Securities Act of 1933, as amended, other obligations of the parties and termination provisions. In addition, pursuant to the terms of the Underwriting Agreement and related “lock-up” agreements, the Company, each director and executive officer of the Company, and certain stockholders have agreed with the Representative not to offer for sale, issue, sell, contract to sell, pledge or otherwise dispose of any of our Common Stock or securities convertible into Common Stock for a period of 180 days after February 9, 2022, the date of the final prospectus.